A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors
Xiaoling Xu(Fujian Agriculture and Forestry University), Yun Fan(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 40
Related Papers
Consensus for HER2 alterations testing in non-small-cell lung cancer
|ESMO Open|2022|110
Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status
|Journal of Autoimmunity|2021|39